Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MMR Vaccine”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Large-scale testing (Phase 3)Study completedNCT01307436
What this trial is testing

Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines

Who this might be right for
Hepatitis A
Crucell Holland BV 327
Not applicableLooking for participantsNCT05571735
What this trial is testing

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Who this might be right for
Covid-19 PandemicsTuberculosis
University of Oxford 133
Not applicableNot Yet RecruitingNCT07338851
What this trial is testing

The Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

Who this might be right for
PolioMeaslesRubella+2 more
China National Biotec Group Company Limited 600
Large-scale testing (Phase 3)Study completedNCT05254561
What this trial is testing

Triple Antigen vs Monoantigen Immunotherapy for Warts

Who this might be right for
Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts
Zagazig University 160
Not applicableStudy completedNCT04567342
What this trial is testing

Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of MMR Vaccination

Who this might be right for
Preventable Disease, VaccineHealth Care Utilization
Children's Hospital Medical Center, Cincinnati 1,312
Testing effectiveness (Phase 2)Study completedNCT00861744
What this trial is testing

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Who this might be right for
RubellaMumpsMeasles+1 more
GlaxoSmithKline 1,259
Large-scale testing (Phase 3)Study completedNCT00263653
What this trial is testing

Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 297
Post-approval studies (Phase 4)Study completedNCT02880865
What this trial is testing

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

Who this might be right for
Encephalitis, JapaneseMeaslesMumps+1 more
PATH 628
Large-scale testing (Phase 3)Study completedNCT00871117
What this trial is testing

Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 478
Early research (Phase 1)Looking for participantsNCT06411691
What this trial is testing

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

Who this might be right for
Colorectal CancerPancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 54
Not applicableUnknownNCT02712203
What this trial is testing

MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.

Who this might be right for
Measles
CHU de Quebec-Universite Laval 5,808
Large-scale testing (Phase 3)Study completedNCT04475081
What this trial is testing

Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis

Who this might be right for
Sepsis Syndrome
Louisiana State University Health Sciences Center in New Orleans 50
Post-approval studies (Phase 4)UnknownNCT02153866
What this trial is testing

The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine

Who this might be right for
Rotavirus
Sichuan Center for Disease Control and Prevention 2,800
Not applicableStudy completedNCT00013871
What this trial is testing

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

Who this might be right for
HIV InfectionsHepatitis BMeasles+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 300
Post-approval studies (Phase 4)Study completedNCT02253407
What this trial is testing

Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children

Who this might be right for
Immune Response to MMR Vaccine
Serum Institute of India Pvt. Ltd. 341
Not applicableEnded earlyNCT00138255
What this trial is testing

Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines

Who this might be right for
MeaslesMumpsRubella+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 32
Post-approval studies (Phase 4)Study completedNCT03780179
What this trial is testing

MMR at 6 Months Trial

Who this might be right for
Meales-mumps-rubella Vaccine
Rigshospitalet, Denmark 6,540
Not applicableUnknownNCT06043232
What this trial is testing

MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas

Who this might be right for
Glioma
Huashan Hospital 360
Testing effectiveness (Phase 2)Ended earlyNCT03050814
What this trial is testing

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004

Who this might be right for
Colorectal TumorsColorectal NeoplasmsColorectal Carcinoma+2 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT01702428
What this trial is testing

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

Who this might be right for
RubellaMeaslesMumps
GlaxoSmithKline 5,016
Next Page